Efficacy and Health-Related Quality of Life Impact of Fecal Microbiota, Live-jslm: A Post Hoc Analysis of PUNCH CD3 Patients at First Recurrence of Clostridioides difficile Infection-Reference-Cited by-同舟云学术

Efficacy and Health-Related Quality of Life Impact of Fecal Microbiota, Live-jslm: A Post Hoc Analysis of PUNCH CD3 Patients at First Recurrence of Clostridioides difficile Infection

Published:2024-01 Issue:1 Volume:13 Page:221-236
ISSN:2193-8229
Container-title:Infectious Diseases and Therapy
language:en
Short-container-title:Infect Dis Ther

Author:

Feuerstadt Paul^ORCID,Allegretti Jessica R.,Dubberke Erik R.,Guo Amy,Harvey Adam,Yang Min^ORCID,Garcia-Horton Viviana^ORCID,Fillbrunn Mirko,Tillotson Glenn,Bancke Lindy L.,LaPlante Kerry,Garey Kevin W.,Khanna Sahil

Funder

Ferring Pharmaceuticals

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40121-023-00907-w.pdf

Reference48 articles.

1. Cho JM, Pardi DS, Khanna S. Update on treatment of Clostridioides difficile infection. Mayo Clin Proc. 2020;95(4):758–69.

2. Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States 2019. https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats-report-508.pdf. Accessed Dec 2022.

3. Desai K, Gupta SB, Dubberke ER, Prabhu VS, Browne C, Mast TC. Epidemiological and economic burden of Clostridium difficile in the United States: estimates from a modeling approach. BMC Infect Dis. 2016;16(1):1–10.

4. Zhang S, Palazuelos-Munoz S, Balsells EM, Nair H, Chit A, Kyaw MH. Cost of hospital management of Clostridium difficile infection in United States—a meta-analysis and modelling study. BMC Infect Dis. 2016;16(1):1–18.

5. Feuerstadt P, Theriault N, Tillotson G. The burden of CDI in the United States: a multifactorial challenge. BMC Infect Dis. 2023;23(1):1–8.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights into Gut Dysbiosis: Inflammatory Diseases, Obesity, and Restoration Approaches;International Journal of Molecular Sciences;2024-09-08

2. Fighting against Clostridioides difficile infection: Current medications;International Journal of Antimicrobial Agents;2024-07